These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12831371)

  • 21. FTY720: mechanism of action and potential benefit in organ transplantation.
    Brinkmann V
    Yonsei Med J; 2004 Dec; 45(6):991-7. PubMed ID: 15627289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine.
    Mansoor M; Melendez AJ
    Rev Recent Clin Trials; 2008 Jan; 3(1):62-9. PubMed ID: 18474015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs.
    Furukawa H; Suzuki T; Jin MB; Yamashita K; Taniguchi M; Magata S; Ishikawa H; Ogata K; Masuko H; Shimamura T; Fukai M; Hayashi T; Fujita M; Nagashima K; Omura T; Kishida A; Todo S
    Transplantation; 2000 Jan; 69(2):235-41. PubMed ID: 10670633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation.
    Suzuki S; Enosawa S; Kakefuda T; Shinomiya T; Amari M; Naoe S; Hoshino Y; Chiba K
    Transplantation; 1996 Jan; 61(2):200-5. PubMed ID: 8600623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The FTY720 story.
    Napoli KL
    Ther Drug Monit; 2000 Feb; 22(1):47-51. PubMed ID: 10688258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of a novel immunosuppressant, FTY720, in mice without secondary lymphoid organs.
    Sugito K; Koshinaga T; Inoue M; Ikeda T; Hagiwara N; Fukuzawa M
    Surg Today; 2005; 35(8):662-7. PubMed ID: 16034547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants.
    Yopp AC; Ledgerwood LG; Ochando JC; Bromberg JS
    Clin Transplant; 2006; 20(6):788-95. PubMed ID: 17100731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons.
    Quesniaux V; Fullard L; Arendse H; Davison G; Markgraaff N; Auer R; Ehrhart F; Kraus G; Schuurman HJ
    Transpl Immunol; 1999 Sep; 7(3):149-57. PubMed ID: 10608298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.
    Tedesco-Silva H; Pescovitz MD; Cibrik D; Rees MA; Mulgaonkar S; Kahan BD; Gugliuzza KK; Rajagopalan PR; Esmeraldo Rde M; Lord H; Salvadori M; Slade JM;
    Transplantation; 2006 Dec; 82(12):1689-97. PubMed ID: 17198261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FTY720 in corneal concordant xenotransplantation.
    Sedláková K; Muckersie E; Robertson M; Filipec M; Forrester JV
    Transplantation; 2005 Feb; 79(3):297-303. PubMed ID: 15699759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current perspectives on FTY720.
    Martini S; Peters H; Böhler T; Budde K
    Expert Opin Investig Drugs; 2007 Apr; 16(4):505-18. PubMed ID: 17371198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of peritransplant FTY720 alone or in combination with post-transplant tacrolimus in a rat model of cardiac allotransplantation.
    Xu M; Pirenne J; Antoniou EA; Afford SC; D'Silva M; McMaster P
    Transpl Int; 1998; 11(4):288-94. PubMed ID: 9704394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An effect of FTY720 on acute rejection in canine renal transplantation.
    Yuzawa K; Otsuka M; Taniguchi H; Takada Y; Sakurayama N; Jinzenji Y; Suzuki S; Fukao K
    Transplant Proc; 1998 Jun; 30(4):1046. PubMed ID: 9636422
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel immunosuppressant, FTY720, increases the efficiency of a superantigen-induced peripheral T-cell deletion whilst inhibiting negative selection in the thymus.
    Shimizu C; Li X; Kimura M; Hashimoto K; Sugaya K; Kubo M; Suzuki S; Nakayama T
    Immunology; 1998 Aug; 94(4):503-12. PubMed ID: 9767438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
    Yuzawa K; Stephkowski SM; Wang M; Kahan BD
    Transplant Proc; 2000 Mar; 32(2):269. PubMed ID: 10715413
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients.
    Park SI; Felipe CR; Machado PG; Garcia R; Skerjanec A; Schmouder R; Tedesco-Silva H; Medina-Pestana JO
    Braz J Med Biol Res; 2005 May; 38(5):683-94. PubMed ID: 15917949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus and FTY720: new approaches to transplant immunosuppression.
    Kahan BD
    Transplant Proc; 2002 Nov; 34(7):2520-2. PubMed ID: 12431509
    [No Abstract]   [Full Text] [Related]  

  • 39. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
    Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
    Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.